Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA funding note for NIH grant/contract was added to the record, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision on the page updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page revision has been published. This reflects a minor internal update to the page metadata rather than changes to the study's content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision label changed from v3.6.2 to v3.6.3. This indicates a minor update to the page or its assets rather than a change to core content and user-facing features.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build update. This update does not modify the study details or how users interact with the page.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page adds new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment is closed. It also standardizes the Intervention/Treatment heading and updates the site revision from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.